NCT00366418View on ClinicalTrials.gov

Lower But More Frequent Dose Rituximab to Treat Chronic Lymphocytic Leukemia

PHASE1CompletedINTERVENTIONAL
Enrollment

4

Participants

Timeline

Start Date

August 10, 2006

Primary Completion Date

June 11, 2009

Study Completion Date

June 11, 2009

Conditions
Refractory Chronic Lymphocytic Leukemia
Interventions
DRUG

Rituximab

Trial Locations (1)

20892

National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda

All Listed Sponsors
lead

National Heart, Lung, and Blood Institute (NHLBI)

NIH

NCT00366418 - Lower But More Frequent Dose Rituximab to Treat Chronic Lymphocytic Leukemia | Biotech Hunter | Biotech Hunter